Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | KDM6B | O15054 | 1/20 | 0.55 |
| ▸ | KDM5C | P41229 | 1/20 | 0.55 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.55 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.55 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.55 |
| ▸ | MGAM | O43451 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | SI | P14410 | 1/20 | 0.47 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | MMP12 | P39900 | 1/20 | 0.35 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL235434 | 0.96 | KDM4E (0.58) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL10936077 | 0.92 | KDM4E (0.55) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL26967576 | 0.92 | KDM4E (0.55) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28338656 | 0.92 | KDM4E (0.55) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28123714 | 0.92 | KDM4E (0.55) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28706026 | 0.92 | KDM4E (0.55) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28634328 | 0.89 | KDM4E (0.52) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL11219945 | 0.84 | MGAM (0.53) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL1686202 | 0.84 | MGAM (0.53) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL588255 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8852555-B2 | Process for production of surface-coated inorganic particles | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2014-10-07 | — | — | US | disclosed |
| EP-2184262-B1 | PROCESS FOR PRODUCTION OF SURFACE-COATED INORGANIC PARTICLES | TOKYO INST TECH (JP) | 2012-12-26 | — | — | EP | disclosed |
| US-20100254908-A1 | PROCESS FOR PRODUCTION OF SURFACE-COATED INORGANIC PARTICLES | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2010-10-07 | — | — | US | disclosed |
| EP-2184262-A1 | PROCESS FOR PRODUCTION OF SURFACE-COATED INORGANIC PARTICLES | Tokyo Institute of Technology (JP) | 2010-05-12 | — | — | EP | disclosed |
| CN-1281470-A | Cycloolefin polymer reduced in catalyst residue content, use thereof, and process for producing same | TEIJIN LTD (JP) | 2001-01-24 | — | — | CN | disclosed |
| US-4641059-A | CHELATION OF ORGANOMETAL ACCELERATOR IN ADHESIVE RESINS; HIGH RESOLUTION | SONY CORPORATION (JP) | 1987-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100254908-A1 | PROCESS FOR PRODUCTION OF SURFACE-COATED INORGANIC PARTICLES | SLC27A1, SLC27A2, CS | KDM4E 3850/4885KDM6B 3492/4885KDM5C 3472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.